(Q33838981)

29 July 2017

1 reference

title

Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology? (English)

1 reference

29 July 2017

1 reference

myelodysplastic syndrome

1 reference

1 reference

Barrett J

1

1 reference

29 July 2017

Saunthararajah Y

series ordinal

2

1 reference

29 July 2017

Molldrem J

series ordinal

3

1 reference

29 July 2017

language of work or name

1 reference

1 January 2000

1 reference

29 July 2017

Seminars in Hematology

1 reference

29 July 2017

37

1 reference

29 July 2017

1

1 reference

29 July 2017

15-29

1 reference

Clonal analysis of peripheral blood and haemopoietic colonies in patients with aplastic anaemia and refractory anaemia using the polymorphic short tandem repeat on the human androgen-receptor (HUMARA) gene

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Proposals for the classification of the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Immunosuppressive therapy for hypoplastic myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

ICE, mini-ICE or high-dose hydroxyurea to mobilize Philadelphia (Ph1)-negative PBPC in chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Megakaryocyte, erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Bone marrow histopathology of patients with severe aplastic anaemia before treatment and at follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Hematopoietic progenitor cells from patients with myelodysplastic syndromes: in vitro colony growth and long-term proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Aplastic anaemia and the hypocellular myelodysplastic syndrome: histomorphological, diagnostic, and prognostic features

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

The bone marrow in aplastic anaemia: Diagnostic and prognostic features

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Deficiency of pluripotent hemopoietic progenitor cells in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

NORMAL VARIATIONS WITH AGING OF THE AMOUNT OF HEMATOPOIETIC TISSUE IN BONE MARROW FROM THE ANTERIOR ILIAC CREST. A STUDY MADE FROM 177 CASES OF SUDDEN DEATH EXAMINED BY NECROPSY

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Clonality in hematopoietic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Sustained trilineage recovery and disappearance of abnormal chromosome clone in a patient with myelodysplastic syndrome following combination therapy with cytokines (granulocyte colony-stimulating factor and erythropoietin) and high-dose methylpredn

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Diagnostic and prognostic significance of cytogenetics in adult primary myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

The impact of the new fish technologies on the cytogenetics of haematological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Diagnostic significance of detecting pseudo-Pelger-Huët anomalies and micro-megakaryocytes in myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Fas/APO-1 (CD95) expression in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Phenotypic and functional analysis of bone marrow progenitor cell compartment in bone marrow failure

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

T-cell receptor beta chain variability in bone marrow and peripheral blood in severe acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Hypoplastic myelodysplastic syndrome: incidence, morphology, cytogenetics, and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Bone Marrow Graft in Man after Conditioning by Antilymphocytic Serum

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Multiple chromosomally distinct cell populations in myelodysplastic syndromes and their possible significance in the evolution of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Low-dose cyclosporin for severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Analysis of T-cell clonality in bone marrow of patients with acquired aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Clonal analysis of CD4+/CD8+ T cells in a patient with aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Antithymocyte globulin for patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Hypoplastic myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Long-term follow-up of aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

gamma-Interferon gene expression in the bone marrow of patients with aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Effect of androgen therapy and anemia on serum erythropoietin levels in patients with aplastic anemia and myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Detection of tumor necrosis factor-alpha in bone marrow plasma and peripheral blood plasma from patients with aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

The occurrence subtype and significance of haemopoietic inhibitory T cells (HIT cells) in myelodysplasia: An in vitro study

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Correction of aplastic anaemia complicating paroxysmal nocturnal haemoglobinuria: absence of eradication of the PNH clone and dependence of response on cyclosporin A administration

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Cyclosporine in refractory severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

T cell‐mediated inhibition of erythropoiesis in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Antilymphocyte globulin for myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Bone marrow histology in myelodysplastic syndromes. II. Prognostic value of abnormal localization of immature precursors in MDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Clonal haematopoiesis in children with acquired aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Reference standards for bone marrow cellularity

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Hypocellular myelodysplastic syndromes (MDS): new proposals.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

Myelodysplasia following paroxysmal nocturnal haemoglobinuria: evidence for the emergence of a separate clone

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

The pathophysiology of acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

MHC-antigen interaction: what does the T cell receptor see?

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990027-1

7 January 2021

10.1016/S0037-1963(00)90027-1

Identifiers

DOI

1 reference

29 July 2017

1 reference